Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance.
Schlagenhauf P, Steffen R, Lobel H, Johnson R, Letz R, Tschopp A, Vranjes N, Bergqvist Y, Ericsson O, Hellgren U, Rombo L, Mannino S, Handschin J, Stürchler D.
Schlagenhauf P, et al. Among authors: sturchler d.
Trop Med Int Health. 1996 Aug;1(4):485-94. doi: 10.1046/j.1365-3156.1996.d01-85.x.
Trop Med Int Health. 1996.
PMID: 8765456
Free article.